Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Tumor-Agnostic 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Lung Neoplasms 2Weight Loss 1Gastrointestinal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Anorexia 1

Interventions

Carboplatin 283Cisplatin 225Pemetrexed 196Paclitaxel 151Docetaxel 132pembrolizumab 109Gemcitabine 94Etoposide 64Erlotinib Hydrochloride 59Radiotherapy 54Vinorelbine 47durvalumab 46Gefitinib 46Bevacizumab 46atezolizumab 42Nivolumab 40Drug Therapy 34osimertinib 30Topotecan 29tislelizumab 23130-nm albumin-bound paclitaxel 23Radiosurgery 21Ipilimumab 18Crizotinib 18Magnetic Resonance Spectroscopy 15Albumin-Bound Paclitaxel 15Surgical Procedures, Operative 14aumolertinib 13Platinum 13Injections 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Melatonin × Thoracic × Clear all
NCT00668707 2021-08-03

AMPLCaRe

The Canadian College of Naturopathic Medicine

Phase 3 Completed
709 enrolled 25 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00513357 2012-12-11

Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
82 enrolled 7 charts
GastrointestinalThoracic

Anorexia, Cachexia, Gastrointestinal Neoplasms, Lung Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡